Search icon

FRONTIER PHARMACEUTICAL, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: FRONTIER PHARMACEUTICAL, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 18 Aug 1993 (32 years ago)
Entity Number: 1750337
ZIP code: 11747
County: Suffolk
Place of Formation: New York
Address: 10 PONDEROSA DRIVE, MELVILLE, NY, United States, 11747

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent 10 PONDEROSA DRIVE, MELVILLE, NY, United States, 11747

Chief Executive Officer

Name Role Address
HOWARD ALLIGER Chief Executive Officer 10 PONDEROSA DRIVE, MELVILLE, NY, United States, 11747

Unique Entity ID

CAGE Code:
64ER6
UEI Expiration Date:
2018-03-08

Business Information

Activation Date:
2017-03-08
Initial Registration Date:
2010-09-07

Commercial and government entity program

CAGE number:
64ER6
Status:
Obsolete
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-03-04
CAGE Expiration:
2022-03-08

Contact Information

POC:
VALERIE ALLIGER-BOGRAD
Corporate URL:
www.frontierpharm.com

History

Start date End date Type Value
2003-10-03 2009-07-30 Address 10 PONDEROSA DRIVE, MELVILLE, NY, 11747, USA (Type of address: Principal Executive Office)
2003-10-03 2009-07-30 Address 10 PONDEROSA DRIVE, MELVILLE, NY, 11747, USA (Type of address: Service of Process)
2003-10-03 2009-07-30 Address 10 PONDEROSA DRIVE, MELVILLE, NY, 11747, USA (Type of address: Chief Executive Officer)
2000-11-15 2003-10-03 Address 135 SPAGNOLI ROAD, MELVILLE, NY, 11747, USA (Type of address: Service of Process)
2000-11-07 2003-10-03 Address 135 SPAGNOLI RD, MELVILLE, NY, 11747, USA (Type of address: Chief Executive Officer)

Filings

Filing Number Date Filed Type Effective Date
110831002076 2011-08-31 BIENNIAL STATEMENT 2011-08-01
090730002534 2009-07-30 BIENNIAL STATEMENT 2009-08-01
070821002418 2007-08-21 BIENNIAL STATEMENT 2007-08-01
051014002415 2005-10-14 BIENNIAL STATEMENT 2005-08-01
031003002531 2003-10-03 BIENNIAL STATEMENT 2003-08-01

USAspending Awards / Financial Assistance

Date:
2021-02-18
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
37605.00
Total Face Value Of Loan:
37605.00
Date:
2020-04-30
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
36764.50
Total Face Value Of Loan:
36764.50

Trademarks Section

Serial Number:
97891365
Status:
REGISTERED
Mark Type:
TRADEMARK
Application Filing Date:
2023-04-17
Mark Drawing Type:
Illustration: Drawing or design without any word(s)/letter(s)/number(s)

Goods And Services

For:
antimicrobial, medicated chlorine-dioxide formulations for disinfection, wound healing, deodorizing, cleaning, whitening, biofilm removal and cancer treatment
First Use:
1999-06-01
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
97435263
Mark:
EARIGANT
Status:
REGISTERED
Mark Type:
TRADEMARK
Application Filing Date:
2022-05-31
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
EARIGANT

Goods And Services

For:
Disinfectant for veterinary use
First Use:
1998-10-05
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
97435248
Mark:
CIDERM
Status:
REGISTERED
Mark Type:
TRADEMARK
Application Filing Date:
2022-05-31
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
CIDERM

Goods And Services

For:
antimicrobial preparation for use on pets, livestock and exotic animals for treating bacterial, viral, yeast and fungal infections in wounds, inflammation(s), dermal leasions and burns
First Use:
1999-12-18
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
97434365
Status:
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Mark Type:
TRADEMARK
Application Filing Date:
2022-05-30
Mark Drawing Type:
Illustration: Drawing or design without any word(s)/letter(s)/number(s)

Goods And Services

For:
antimicrobial chlorine-dioxide based toothpaste and mouthwash; medicated, topical treatment for nail fungus, containing chlorine dioxide, for removing fungal infection and improving an appearance of nails damaged by fungal infection
First Use:
1999-06-01
International Classes:
005 - Primary Class
Class Status:
Active
For:
chlorine dioxide based toothpaste and mouthwash
First Use:
1999-06-01
International Classes:
003 - Primary Class
Class Status:
Active
Serial Number:
97434324
Mark:
WUZAWART
Status:
REGISTERED
Mark Type:
TRADEMARK
Application Filing Date:
2022-05-30
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
WUZAWART

Goods And Services

For:
A medicated, topical treatment preparation for warts, containing a chlorine dioxide complex that kills the virus and removes the wart
First Use:
2002-12-01
International Classes:
005 - Primary Class
Class Status:
Active

Paycheck Protection Program

Jobs Reported:
4
Initial Approval Amount:
$36,764.5
Date Approved:
2020-04-30
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$36,764.5
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$37,084.8
Servicing Lender:
Santander Bank, National Association
Use of Proceeds:
Payroll: $36,764.5
Jobs Reported:
4
Initial Approval Amount:
$37,605
Date Approved:
2021-02-18
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$37,605
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$37,755.42
Servicing Lender:
Santander Bank, National Association
Use of Proceeds:
Payroll: $37,602
Utilities: $1

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 15 Mar 2025

Sources: New York Secretary of State